1)Gonzalez JG, Elizondo G, Saldivar D, et al: Pituitary gland growth during normal pregnancy: an in vivo study using magnetic resonance imaging. Am J Med 85: 217, 1988.
2)Miki Y, Asato R, Okumura R, et al: Anterior pituitary gland in pregnancy: hyperintensity at MR. Radiology 187: 229, 1993.
3)Goluboff LG, Ezrin C: Effect of pregnancy on the somatotroph and the prolactin cell of the human adenohypophysis. J Clin Endocrinol Metab 29: 1533, 1969.
4)Scheithauer BW, Sano T, Kovacs KT, et al: The pituitary gland in pregnancy: a clinicopathologic and immunohistochemical study of 69 cases. Mayo Clin Proc 65: 461, 1990.
5)Stefaneanu L, Powell-Braxton L, Won W, Chandrashekar V, Bartke A: Somatotroph and lactotroph changes in the adenohypophyses of mice with disrupted insulin-like growth factor I gene. Endocrinology 140: 3881, 1999.
6)Elster AD, Sanders TG, Vines FS, Chen, MYM. Size and shape of the pituitary gland during pregnancy and postpartum: measurement with MR imaging. Radiology 181: 531, 1991.
7)Dinc H, Esen F, Demirici A, et al. Pituitary dimensions and volume measurements in pregnancy and post partum: MR assessment. Acta Radiol 39: 64, 1998.
8)Freeman ME, Kanyicska B, Lerant A, Nagy G: Prolactin: structure, function, and regulation of secretion. Physiological Reviews 80: 1523, 2000.
9)Vician L, Shupnik MA, Gorski J: Effects of estrogen on primary ovine pituitary cell cultures: stimulation of prolactin secretion, synthesis, and preprolactin messenger ribonucleic acid activity. Endocrinology 104: 736, 1979.
10)Maurer RA: Relationship between estradiol, ergocryptine, and thyroid hormone: effects on prolactin synthesis and prolactin messenger ribonucleic acid levels. Endocrinology 110: 1515, 1982.
11)Rakoff JS, Yen SSC: Progesterone induced acute release of prolactin in estrogen primed ovariectomized women. J Clin Endocrinol Metab 47: 918, 1978.
12)Maslar IA, Ansbacher R: Effects of progesterone on decidual prolactin production by organ cultures of human endometrium. Endocrinol 118: 2102, 1986.
13)Rigg LA, Lein A, Yen SSC: Pattern on increase in circulating prolactin levels during human gestation. Am J Obstet Gynecol 129: 454, 1977.
14)Frankenne F, Closset J, Gomez F, et al: The physiology of growth hormones (GHs) in pregnant women and partial characterization of the placental GH variant. J Clin Endocrinol Metab 66: 1171, 1988.
15)Eriksson L, Frankenne F, Eden S, et al: Growth hormone 24-h serum profiles during pregnancy—lack of pulsatility for the secretion of the placental variant. Br J Obstet Gynaecol 106: 949, 1989.
16)Goodman HM, Tai L-R, Ray J, et al: Human growth hormone variant produces insulin-like and lipolytic responses in rat adipose tissue. Endocrinology 129: 1779, 1991.
17)MacLeod JN, Worsley I, Ray J, et al: Human growth hormone-variant is a biologically active somatogen and lactogen. Endocrinology 128: 1298, 1991.
18)Caufriez A, Frankenne F, Enlert Y, et al: Placental growth hormone as a potential regulator of maternal IGF-1 during human pregnancy. Am J Physiol 258: E1014, 1990.
19)Von Werder K, Muller OA, Harth R, et al: Growth hormone releasing factor stimulation test in normal controls. J Endocrinol Invest 7: 185, 1984.
20)Beckers A, Stevenaert A, Foidart J-M, et al: Placental and pituitary growth hormone secretion during pregnancy in acromegalic women. J Clin Endocrinol Metab 71: 725, 1990.
21)Yoshimura M, Hershman JM: Thyrotropic action of human chorionic gonadotropin. Thyroid 5: 425, 1995.
22) Goodwin TM, Hershman JM: Hyperthyroidism due to inappropriate production of human chorionic gonadotropin. Clin Obstet Gynecol 40:32, 1997.
23) Pekonen F, Alfthan H, Stenman U-H, Ylikorkala O: Human chorionic gonadotropin (hCG) and thyroid function in early human pregnancy: circadian variation and evidence for intrinsic thyrotropic activity of hCG. J Clin Endocrinol Metab 66: 853, 1988.
24)Glinoer D: The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev 18: 404, 1997.
25)Glinoer D, de Nayer P, Bourdoux P, et al: Regulation of maternal thyroid during pregnancy. J Clin Endocrinol Metab 71: 276, 1990.
26)Glinoer D, De Nayer P, Robyn C, Lejeune B, Kinthaert J, Meuris S: Serum levels of intact human chorionic gonadotropin (hCG) and its free and subunits, in relation to maternal thyroid stimulation during normal pregnancy. J Endocrinol Invest 16: 881, 1993.
27) Ginsberg J, Lewanczuk RZ, Honore LH: Hyperplacentosis: a novel cause of hyperthyroidism. Thyroid 11: 393, 2001.
28) Gruen JP, Meuris S, De Nayer P, Glinoer D: The thyrotropic role of human chorionic gonadotropin (hCG) in the early stages of twin (vs. single) pregnancy. J Clin Endocrinol 46: 719, 1997.
29) Thodou E, Asa SL, Kontogeorgos G, et al. Lymphocytic hypophysitis: clinicopathological findings. J Clin Endocrinol Metab 80:2302, 1995.
30) Harada K, Hershman JM, Reed AW, et al. Comparison of thyroid stimulators and thyroid hormone concentrations in the sera of pregnant women. J Clin Endocrinol Metab 48:793, 1979.
31)Jeppsson S, Rannevik G, Liedholm P, et al: Basal and LHRH stimulated secretion of FSH during pregnancy. Am J Obstet Gynecol 127: 32, 1977.
32)Stalla GK, Bost H, Stalla J, et al: Human corticotrophin releasing hormone during pregnancy. Gynecol Endocrinol 3: 1, 1989.
33)Rees LH, Burke CW, Chard T, et al: Possible placental origin of ACTH in normal human pregnancy. Nature 254: 620, 1975.
34)Sasaki A, Shinkawa O, Yoshinaga K. Placental corticotrophin-releasing hormone may be a stimulator of maternal pituitary adrenocorticotropic hormone secretion in humans. J Clin Invest 84: 1997, 1989.
35)Carr BR, Parker CR Jr, Madden JE, et al: Maternal plasma adrenocorticotropin and cortisol relationships throughout human pregnancy. Am J Obstet Gynecol 139: 416, 1981.
36)Nolten WE, Lindheimer MD, Rueckert PA, et al: Diurnal patterns and regulation of cortisol secretion in pregnancy. J Clin Endocrinol Metab 51: 466, 1980.
37)Central Brain Tumor Registry of the United States. Statistical report: primary brain tumors in the US 1998-2002. Available at http://www.cbtrus.org. Accessed 15 January 2006.
38)Kredentser JV, Hoskins CF, Scott JZ: Hyperprolactinemia: a significant factor in female infertility. Am J Obstet Gynecol 139: 264, 1981.
39)Molitch ME: Disorders of prolactin secretion. Endocrinol Metab Clin N Amer. 30:585, 2001.
40)Bevan JS, Webster J, Burke CW, Scanlon MF. Dopamine agonist and pituitary tumor shrinkage. Endocr Rev 13: 220, 1992.
41)Webster J, Piscitelli G, Polli A, et al: A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. N Engl J Med 331: 904, 1994.
42)Biller BMK, Molitch ME, Vance ML, et al: Treatment of prolactin-secreting macroadenomas with the once-weekly dopamine agonist cabergoline. J Clin Endocrinol Metab 81: 2338, 1996.
43)Verhelst J, Abs R, Maiter D, et al: Cabergoline in the treatment of hyperprolactinemia. J Clin Endocrinol Metab 84: 2518, 1999.
44)Molitch ME. Dopamine resistance of prolactinomas. Pituitary 6: 19, 2003.
45)Colao A, DiSarno A, Landi ML, et al: Macroprolactinoma shrinkage during cabergoline treatment is greater in naïve patients than in patients pretreated with other dopamine agonists: a prospective study of 110 patients. J Clin Endocinol Metab 85: 2247, 2000.
46) Gillam MP, Molitch ME, Lombardi G, Colao A. Advances in the treatment of prolactinomas. Endocrine Rev. In Press.
47) Molitch ME. Pituitary disorders during pregnancy. Endocrinol Metab Clin N Am 35: 99, 2006.
48)Liu C, Tyrrell JB: Successful treatment of a large macroprolactinoma with cabergoline during pregnancy. Pituitary 4: 179, 2001.
49)Bigazzi M, Ronga R, Lancranjan I, et al: A pregnancy in an acromegalic woman during bromocriptine treatment: effects on growth hormone and prolactin in the maternal, fetal, and amniotic compartments. J Clin Endocrinol Metab 48: 9, 1979.
50)Krupp P, Monka C, Richter K. The safety aspects of infertility treatments. In: Program of the Second World Congress of Gynecology and Obstetrics, Rio de Janeiro, Brazil, 9, 1988.
51)Raymond JP, Goldstein E, Konopka P, et al: Follow-up of children born of bromocriptine-treated mothers. Horm Res 22: 239, 1985.
52)Buelke-Sam J, Byrd RA, Johnson JA, et al: Developmental toxicity of the dopamine agonist pergolide mesylate in CD-1 mice: I. gestational exposure. Neruotoxicol Teratol 13: 283, 1991.
53)De Mari M, Zenzola A, Lamberti P. Antiparkinsonian treatment in pregnancy. Mov Disord 17: 428, 2002.
54)Acharya V. Review of pregnancy reports in patients on pergolide treatment. Data on file. Indianapolis (IN): Eli Lilly & Co., 2004.
55)Webster J: A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation. Drug Saf 14: 228, 1996.
56)Robert E, Musatti L, Piscitelli G, Ferrari CI: Pregnancy outcome after treatment with the ergot derivative, cabergoline. Reprod Toxicol 10: 333, 1996.
57) Garceau R: Pregnancies reported to Pharmacia Upjohn in patients receiving cabergoline. Data on file. Kalamazoo (MI): Pharmacia & Upjohn, 1997.
58)Liu C, Tyrrell JB: Successful treatment of a large macroprolactinoma with cabergoline during pregnancy. Pituitary 4: 179, 2001.
59)Verhelst J, Abs R, Maiter D, et al: Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients. J Clin Endocrinol Metab 84: 2518, 1999.
60)Ricci E, Parazzini F, Motta T, et al: Pregnancy outcome after cabergoline treatment in early weeks of gestation. Reprod Toxicol 16: 791, 2002.
61)Musolino NRC, Bronstein MD. Prolactinomas and pregnancy. In: Bronstein MD, editor. Pituitary tumors and pregnancy. Norwell (MA): Kluwer Academic Publishers: p. 91-108, 2001.
62)Divers WA, Yen SSC: Prolactin-producing microadenomas in pregnancy. Obstet Gynecol 62: 425, 1983.
63) Corenblum B, Donovan L: The safety of physiological estrogen plus progestin replacement therapy and with oral contraceptive therapy in women with pathological hyperprolactinemia. Fertil Steril 59: 671, 1993.
64) Jadresic A, Banks LM, Child DF, et al: The acromegaly syndrome: relation between clinical features, growth hormone values and radiological characteristics of the pituitary tumors. Q J Med 51: 189, 1982.
65) Molitch ME: Clinical manifestations of acromegaly. Endocrinol Metab Clin North Am 21: 597, 1992.
66) Nagamani M, Lingold JC, Gomez LG: Hyperthecosis of the ovaries in acromegaly. Obstet Gynecol 56: 258, 1980.
67) Advis JP, White SS, Ojeda SR: Activation of growth hormone short loop negative feedback delays puberty in the female rat. Endocrinololgy 108: 1343, 1981.
68) Hsu CJ, Hammond JM: Concomitant effects of growth hormone on secretion of insulin-like growth factor I and progesterone by cultured porcine granulosa cells. Endocrinology 121: 1343, 1987.
69) Beckers A, Stevenaert A, Foidart J-M, et al: Placental and pituitary growth hormone secretion during pregnancy in acromegalic women. J Clin Endocrinol Metab 71: 725,1990.
70) Barkan AL, Stred SE, Reno K, et al: Increased growth hormone pulse frequency in acromegaly. J Clin Endocrinol Metab 69: 1225, 1989.
71) Wilson DM, Bennett A, Adamson GD, et al: Somatomedins in pregnancy: a cross-sectional study of insulin-like growth factors I and II and somatomedin peptide content in normal human pregnancies. J Clin Endocrinol Metab 55: 858, 1982.
72) Herman-Bonert V, Seliverstov M, Melmed S: Pregnancy outcome in acromegaly: successful therapeutic outcome. J Clin Endocrinol Metab 83: 727, 1998.
73) Kupersmith MJ, Rosenberg C, Kleinberg D: Visual loss in pregnant women with pituitary adenomas. Ann Intern Med 121: 473, 1994.
74) Okada Y, Morimoto I, Ejima K, et al: A case of active acromegalic woman with a marked increase in serum insulin-like growth factor-1 levels after delivery. Endocr J 44: 117, 1997.
75) Colao A, Merola B, Ferone D, Lombardi G: Acromegaly. J Clin Endocrinol Metab 82: 2777, 1997.
76) Takeuchi K, Funakoshi T, Oomori S, Maruo T: Successful pregnancy in an acromegalic woman treated with octreotide. Obstet Gynecol 93: 848, 1999.
77) Fassnacht M, Capeller B, Arlt W, et al: Octreotide LAR treatment throughout pregnancy in an acromegalic woman. Clin Endocrinol 55: 411, 2001.
78) De Menis E, Billeci D, Marton E: Uneventful pregnancy in an acromegalic patient treated with slow-release lanreotide: a case report. J Clin Endocrinol Metab 84: 1489, 1999.
79). Sanchez R, Boix E, delPino Navarro M, Pico A: Pregnancy in an acromegalic patient treated with lanreotide and bromocryptin. Medicina Clinica 113: 198, 1999.
80) Caron P, Gerbeau C, Pradayrol L, et al: Successful pregnancy in an infertile woman with a thyrotropin-secreting macroadenoma treated with somatostatin analog (octreotide). J Clin Endocrinol Metab 81: 1164, 1996.
81) Caron P, Bennet A, Lorenzini F, et al: Normal pregnancy in a woman with nesidioblastosis treated with somatostatin analog octreotide. Prog 81st Annual Meeting of the Endocrine Society, San Diego, 1999.
82) Caron P, Gerbeau C, Pradayrol L: Maternal-fetal transfer of octreotide. N Engl J Med 333: 601, 1995.
83)Caron P, Gerbeau C, Pradayrol L, et al: Successful pregnancy in an infertile woman with a thyrotropin-secreting macroadenoma treated with the somatostatin analog (octreotide). J Clin Endocrinol Metab 81: 1164, 1996.
84)Blackhurst G, Strachan MW, Collie D, et al: The treatment of a thyrotropin-secreting pituitary macroadenoma with octreotide in twin pregnancy. Clin Endocrinol (Oxf) 56: 401, 2002.
85)Chaiamnuay S, Moster M, Katz MR, Kim YN: Successful management of a pregnant woman with a TSH-secreting pituitary adenoma with surgical and medical therapy. Pituitary 6: 109, 2003.
86)Molitch ME: Clinically non-functioning adenomas. In Bronstein MD, editor. Pituitary tumors and pregnancy. Norwell (MA): Kluwer Academic Publishers, p. 123-9, 2001.
87)Kupersmith MJ, Rosenberg C, Kleinberg D: Visual loss in pregnant women with pituitary adenomas. Ann Intern Med 121: 473, 1994.
88)Masding MG, Lees PD, Gawne-Cain ML, Sandeman DD: Visual field compression by a non-secreting pituitary tumor during pregnancy. J R Soc Med 96: 27, 2003.
89)Murata Y, Ando H, Nagasaka T, et al: Successful pregnancy after bromocriptine therapy in an anovulatory woman complicated with ovarian hyperstimulation caused by follicle-stimulating hormone-producing plurihormonal pituitary macroadenoma. J Clin Endocrinol Metab 88: 1988, 2003.
90)Sugita T, Seki K, Nagai Y, et al: Successful pregnancy and delivery after removal of gonadotrope adenoma secreting follicle-stimulating hormone in a 29-year-old amenorrheic woman. Gynecol Obstet Invest 59: 138, 2005.
91)Sheehan HL, Davis JC: Pituitary necrosis. Br Med Bull 24: 59, 1968.
92) Kelestimur F: Sheehan’s syndrome. Pituitary 6: 181, 2003.
93)Feinberg E, Molitch M, Endres L, Peaceman A. The incidence of Sheehan’s syndrome after obstetric hemorrhage. Fertil Steril 84: 975, 2005.
94)Ozbey N, Inanc S, Aral F, et al: Clinical and laboratory evaluation of 40 patients with Sheehan’s syndrome. Isr J Med Sci 30: 826, 1994.
95) Sheehan HL: The neurohypophysis in post-partum hypopituitarism. J Pathol Bacteriol 85: 145, 1963.
96) Iwasaki Y, Oiso Y, Yamauchi K, et al: Neurohypophyseal function in post-partum hypopituitarism: impaired plasma vasopressin response to osmotic stimuli. J Clin Endocrinol Metab 68: 560, 1989.
97) Bakiri F, Bendib S-E, Maoui R, et al: The sella turcica in Sheehan’s syndrome: computerized tomographic study in 54 patients. J Endocrinol Invest 14: 193, 1991.
98) Caturegli P, Newschaffer C, Olivi A, Pomper MG, Burger PC, Rose NR: Autoimmune hypophysitis. Endocrine Reviews 26: 599, 2005.
99)O’Dwyer DT, Clifton V, Hall A, Smith R, Robinson PJ, Crock PA: Pituitary autoantibodies in lymphocytic hypophysitis target both and enolase – a link with pregnancy? Arch Physiol Biochem 110: 94, 2002.
100)Pressman EK, Zeidman SM, Reddy UM, et al: Differentiating lymphocytic adenohypophysitis from pituitary adenoma in the peripartum patient. J Reprod Med 40: 251, 1995.
101) Thodou E, Asa SL, Kontogeorgos G, et al: Lymphocytic hypophysitis: clinicopathological findings. J Clin Endocrinol Metab 80: 2302, 1995.
102) Nishiki M, Murakami Y, Ozawa Y, Kato Y: Serum antibodies to human pituitary membrane antigens in patients with autoimmune lymphocytic hypophysitis and infundibuloneurohypophysitis. Clin Endocrinol (Oxf) 54: 327, 2001.
103)Gillam M, Molitch ME: Lymphocytic hypophysitis. In: Bronstein MD, editor. Pituitary tumors and pregnancy. Norwell (MA): Kluwer Academic Publishers, p. 131-148, 2001.
104)Leiba S, Schindel B, Weinstein R, et al: Spontaneous postpartum regression of pituitary mass with return of function. JAMA 255: 230, 1986.
105)McGrail KM, Beyerl BD, Black PM, et al: Lymphocytic adenohypophysitis of pregnancy with complete recovery. Neurosurgery 20: 791, 1987.
106) Lindheimer MD, Davison JM: Osmoregulation, the secretion of arginine vasopressin and its metabolism during pregnancy. Eur J Endocrinol 132: 133, 1995.
107) Davison JM, Shiells EA, Barron WM, et al: Changes in the metabolic clearance of vasopressin and of plasma vasopressinase throughout human pregnancy. J Clin Invest 83: 1313, 1989.
108) Barron WM: Water metabolism and vasopressin secretion during pregnancy. Baillieres Clin Obstet Gynaecol 1: 853, 1987.
109) Durr JA: Diabetes insipidus in pregnancy. Am J Kidney Dis 9: 276, 1987.
110) Huchon DJR, Van Zijl JAWM, Campbell-Brown MB, et al: Desmopressin as a test of urinary concentrating ability in pregnancy. J Obstet Gynecol 2: 206, 1982.
111)Dawood MY, Ylikorkala O, Trivedi D, et al: Oxytocin in maternal circulation and amniotic fluid during pregnancy. J Clin Endocrinol Metab 49: 429, 1979.
112) Russell JA, Leng G, Douglas AJ: The magnocellular oxytocin system, the fount of maternity: adaptations in pregnancy. Frontiers in Neuroendocrinol 24: 27, 2003.
113)Gibbens GLD, Chard T: Observations on maternal oxytocin release during human labor. Am J Obstet Gynecol 126: 243, 1976.
114)Dawood MY, Khan-Dawood FS, Wahi R, et al: Oxytocin release and plasma anterior pituitary and gonadal hormones in women during lactation. J Clin Endocrinol Metab 52: 678, 1981.
115) Soule SG, Monson JP, Jacobs HS: Transient diabetes insipidus in pregnancy—a consequence of enhanced placental clearance of arginine vasopressin. Hum Reprod 10: 3322, 1995.
116) Iwasaki Y, Oiso Y, Kondo K, et al: Aggravation of subclinical diabetes insipidus during pregnancy. N Engl J Med 324: 522, 1991.
117) Yamamoto T, Ishii T, Yoshioka K, et al: Transient central diabetes insipidus in pregnancy with a peculiar change in signal intensity on T1-weighted magnetic resonance images. Intern Med 42: 513, 2003.
118)Barron WM, Cohen LH, Ulland LA, et al: Transient vasopressin-resistant diabetes insipidus of pregnancy. N Engl J Med 310: 442, 1984.
119) Kaellen BAJ, Carlsson SS, Bengtsson BKA: Diabetes insipidus and use of desmopressin (Minirin) during pregnancy. Eur J Endocrinol 132: 144-6, 1995.
120) Ray JG: DDAVP use during pregnancy: an analysis of its safety for mother and child. Obstet Gynecolol Survey 53: 450, 1998.
121) El-Hennawy AS, Bassi T, Koradia N, Bocirnea A: Transient gestational diabetes insipidus: report of two cases and review of pathophysiology and treatment. J Mat-Fet Neonat Med 14: 349, 2003.
122)Kennedy S, Hall PM, Seymour AE, Hague WM: Transient diabetes insipidus and acute fatty liver of pregnancy. Br J Obstet Gynaecol 101: 387, 1994.
123) Krege J, Katz VL, Bowes Jr WA: Transient diabetes insipidus of pregnancy. Obstet Gynecolol Survey 44: 789, 1989.
124) Raziel A, Rosenberg T, Schreyer P, et al: Transient postpartum diabetes insipidus. Am J Obstet Gynecol 164: 616, 1991.
125) Hawker RW, North WG, Colbert IC, Lang LP: Oxytocin blood levels in two cases of diabetes insipidus. Br J Obstet Gynaecol 74: 430, 1987.
126)McLean M, Smith R: Corticotropin-releasing hormone in human pregnancy and parturition. Trends in Endocrinol Metab 10: 174, 1999.
127) Goland RS, Wardlaw SL, Stark RE, et al: High levels of corticotropin-releasing hormone immunoactivity in maternal and fetal plasma during pregnancy. J Clin Endocrinol Metab 63: 1199, 1986.
128) Demey-Ponsart E, Foidart JM, Sulon J, et al: Serum CBG, free and total cortisol and circadian patterns of adrenal function in normal pregnancy. J Steroid Biochem 16: 165, 1982.
129) Dorr HG, Heller A, Versmold HT, et al: Longitudinal study of progestins, mineralocorticoids, and glucocorticoids throughout human pregnancy. J Clin Endocrinol Metab 68: 863, 1989.
130) Whiteley HJ, Stoner HB: The effect of pregnancy on the adrenal cortex. J Endocrinol 14: 325, 1957.
131) Rosenthal HE, Slaunwhite WR, Sandberg AA: Transcortin, a corticosteroid-binding protein of plasma: Cortisol and progesterone interplay and unbound levels of these steroids in pregnancy. J Clin Endocrinol Metab 29: 352, 1969.
132) Brown MA, Wang J, Whitworth JA: The renin-angiotensin-aldosterone system in preeclampsia. Clin Exp Hypertens 19: 713, 1997.
133)Wilson M, Morganti AA, Zervoudakis I, et al: Blood pressure, the renin-aldosterone system and sex steroids throughout normal pregnancy. Am J Med 8: 97, 1980.
134) Boonshaft B, O’Connell JM, Hayes JM, et al: Serum renin activity during normal pregnancy: effect of alterations of posture and sodium intake. J Clin Endocrinol Metab 28: 1641, 1968.
135)Jones KM, Lloyd-Jones R, Riondel A, et al: Aldosterone secretion and metabolism in normal men and women and in pregnancy. Acta Endocrinol 30: 321, 1959.
136)Ehrlich EN, Lindheimer MD: Effect of administered mineralocorticoids or ACTH in pregnant women. Attenuation of kaliuretic influence of mineralocorticoids during pregnancy. J Clin Invest 51: 1301, 1972.
137) Biglieri EG, Slaton, Jr, PE: Pregnancy and primary aldosteronism. J Clin Endocrinol Metab 27: 1628, 1967.
138) Bevan JS, Gough MH, Gillmer MDG, et al. Cushings syndrome in pregnancy. The timing of definitive treatment. Clin Endocrinol (Oxf) 27: 225, 1987.
139) Casson IF, Davis JC, Jeffreys RV, et al. Successful management of Cushings disease during pregnancy by transsphenoidal adenectomy. Clin Endocrinol (Oxf) 27: 423, 1987.
140) Aron DC, Schnall AM, Sheeler LR. Cushings syndrome and pregnancy. Am J Obstet Gynecol 162: 244, 1990.
141) Buescher MA, McClamrock HD, Adashi EY. Cushings syndrome in pregnancy. Obstet Gynecol 79: 130, 1992.
142) Ross RJ, Chew SL, Perry L, et al. Diagnosis and selective cure of Cushing’s disease during pregnancy by transsphenoidal surgery. Europ J Endocrinol 132: 722, 1995.
143) Chico A, Manzanares JM, Halperin I, et al. Cushing’s disease and pregnancy. Eur J Obstet Gynecol Reprod Biol 64: 143, 1996.
144) Guilhaume B, Sanson ML, Billaud L, et al. Cushing’s syndrome and pregnancy: aetiologies and prognosis in twenty-two patients. Eur J Med 1: 83, 1992.
145) Wallace C, Toth EL, Lewanczuk RZ, Siminoski K: Pregnancy-induced Cushing's syndrome in multiple pregnancies. J Clin Endocrinol Metab 81: 15, 1996.
146) Kasperlik-Zaluska AA, Szczupacka I, Leszczynska-Bystrzanowska J, Drus-Przybyszewska G: Pregnancy-dependent Cushing's syndrome in three pregnancies. Br J Obstet Gynaecol 107: 810, 2000.
147) Nolten WE, Lindheimer MD, Rueckert PA, et al. Diurnal patterns and regulation of cortisol secretion in pregnancy. J Clin Endocrinol Metab 51: 466, 1980.
148) Pinette MG, Pan YQ, Oppenheim D, et al. Bilateral inferior petrosal sinus corticotropin sampling with corticotropin-releasing hormone stimulation in a pregnant patient with Cushing’s syndrome. Am J Obstet Gynecol 171: 563, 1994.
149) Kreines K, DeVaux WD. Neonatal adrenal insufficiency associated with maternal Cushings syndrome. Pediatrics 47: 516, 1971.
150) Amado JA, Pesquera C, Gonzalez EM, et al: Successful treatment with ketoconazole of Cushing’s syndrome in pregnancy. Postgrad Med J 66: 221, 1990.
151)Berwaerts J, Verhelst J, Mahler C, Abs R: Cushing’s syndrome in pregnancy treated by ketoconazole: case report and review of the literature. Gynecol Endocrinol 13: 175, 1999.
152)Mellor A, Harvey RD, Pobereskin LH, Sneyd JR: Cushing’s disease treated by trans-sphenoidal selective adenomectomy in mid-pregnancy. Br J Anaesth 80: 850, 1998.
153)Madhun ZT, Aron DC: Cushing’s disease in pregnancy. In: Bronstein MD, editor. Pituitary tumors and pregnancy. Norwell (MA): Kluwer Academic Publishers, p. 149-172, 2001.
154)Hana V, Dokoupilova M, Marek J, Plavka R: Recurrent ACTH-independent Cushing’s syndrome in multiple pregnancies and its treatment with metyrapone. Clin Endocrinol (Oxf) 54: 277, 2001.
155)Lindsay JR, Jonklaas J, Oldfield EH, Nieman LK: Cushing’s syndrome during pregnancy: personal experience and review of the literature. J Clin Endocrinol Metab 90: 3077, 2005.
156)Lindsay JR, Nieman LK: The hypothalamic-pituitary-adrenal axis in pregnancy: challenges in disease detection and treatment. Endocrine Reviews 26: 775, 2005
157)Tajika T, Shinozaki T, Watanabe H, Yangawa T, Takagishi K: Case report of a Cushing’s syndrome patient with multiple pathologic fractures during pregnancy. J Orthop Sci 7: 498, 2002.
158)Putignano P, Toja P, Dubini A, et al: Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing’s syndrome. J Clin Endocrinol Metab 88: 4153, 2003.
159)Magiakou MA, Mastorakos G, Rabin D, et al: The maternal hypothalamic-pituitary-adrenal axis in the third trimester of human pregnancy. Clin Endocrinol (Oxf) 44: 419, 1996.
160)Connell JM, Cordiner J, Davies DL, et al: Pregnancy complicated by Cushing’s syndrome: potential hazard of metyrapone therapy: case report. Br J Obstet Gynaecol 92: 1192, 1985.
161)Close CF, Mann MC, Watts JF, et al: ACTH-independent Cushing’s syndrome in pregnancy with spontaneous resolution after delivery: control of the hypercortisolism with metyrapone. Clin Endocrinol (Oxf) 39: 375, 1993.
162)Gormley MJ, Hadden DR, Kennedy TL, et al: Cushing’s syndrome in pregnancy—treatment with metyrapone. Clin Endocrinol (Oxf) 16: 283, 1982.
163)Albert E, Dalaker K, Jorde R, Berge LN: Addison’s disease and pregnancy. Acta Obstet Gynecol Scand 68:185, 1989.
164) Drucker D, Shumak S, Angel A. Schmidt’s syndrome presenting with intrauterine growth retardation and postpartum Addisonian crisis. Am J Obstet Gynecol 149: 229, 1984.
165) Gamlen TR, Aynsley-Green A, Irvine WJ, McCallum CJ: Immunological studies in the neonate of a mother with Addison’s disease and diabetes mellitus. Clin Exp Immunol 28: 192, 1977.
166) Osler M: Addison’s disease and pregnancy. Acta Endocrinol 41: 67, 1962.
167) O’Shaughnessy RW, Hackett KJ: Maternal Addison’s disease and fetal growth retardation: a case report. J Reprod Med 29: 752, 1984.
168)Gradden C, Lawrence D, Doyle PM, et al: Uses of error: Addison’s disease in pregnancy. Lancet 357: 1197, 2001.
169)Grottolo A, Ferrari V, Mariano M, et al: Primary adrenal insufficiency, circulating lupus anticoagulant and anticardiolipin antibodies in a patient with multiple abortions and recurrent thrombotic episodes. Haematologica 73: 517, 1988.
170)George LD, Selvaraju R, Reddy K, et al: Vomiting and hyponatremia in pregnancy. BJOG 107: 808, 2000.
171)McKenna DS, Wittber GM, Nagaraja HN, et al: The effects of repeat doses of antenatal corticosteroids on maternal adrenal function. Am J Obstet Gynecol 183: 669, 2000.
172)Grinspoon SK, Biller BM. Clinical review 62: laboratory assessment of adrenal insufficiency. J Clin Endocrinol Metab 79: 79: 923, 1994.
173)Nolten WE, Lindheimer MD, Oparil S, et al: Desoxycorticosterone in normal pregnancy: I. sequential studies of the secretory patterns of desoxycorticosterone, aldosterone, and cortisol. Am J Obstet Gynecol 132: 414, 1978.
174)Schulte HM, Weisner D, Allolio B: The corticotrophin releasing hormone test in late pregnancy: lack of adrenocortiocotrophin and cortisol response. Clin Endocrinol (Oxf) 33: 99, 1990.
175)Nigam R, Bhatia E, Miao D, et al: Prevalence of adrenal antibodies in Addison’s disease among north Indian Caucasians. Clin Endocrinol (Oxf) 59: 593, 2003.
176)Symonds EM, Craven DJ: Plasma renin and aldosterone in pregnancy complicated by adrenal insufficiency. Br J Obstet Gynaecol 84: 191, 1977.
177)Seaward PG, Guidozzi F, Sonnendecker EW: Addisonian crisis in pregnancy: case report. Br J Obstet Gynaecol 96: 1348, 1989.
178)Ambrosi B, Barbetta L, Morricone L: Diagnosis and management of Addison’s disease during pregnancy. J Endocrinol Invest 26: 698, 2003.
179)Normington EM, Davies D: Hypertension and oedema complicating pregnancy in Addison’s disease. BMJ 1: 148, 1972.
180) Schlaghecke R, Kornely E, Santen RT, Ridderskamp P. The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone. N Engl J Med 326: 226, 1992.
181) Turner ES, Greenberger PA, Patterson R. Management of the pregnant asthmatic patient. Ann Intern Med 93: 905, 1980.
182) Beitins R, Baynard F, Ances IG, et al: The transplacental passage of prednisone and prednisolone in pregnancy near term. J Pediatr 81: 936, 1972.
183) Kream J, Mulay S, Fukushima DK, et al: Determination of plasma dexamethasone in the mother and the newborn after administration of the hormone in a clinical trial. J Clin Endocrinol Metab 56: 127, 1983.
184) Kenny FM, Preeyasombat C, Spaulding JS, et al. Cortisol production rate. IV. Infants born of steroid-treated mothers and of diabetic mothers. Infants with trisomy syndrome and with anencephaly. Pediatrics 37: 960, 1966.
185) Sidhu RK, Hawkins DR: Prescribing in pregnancy: corticosteroids. Clin Obstet Gynaecol 8: 383, 1981.
186)Garner PR: Congenital adrenal hyperplasia in pregnancy. Sem Perinatol 22:446, 1998.
187) White PC, Speiser PW: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 21: 245, 2000.
188) Forest MG: Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum Reprod Update 10: 469, 2004.
189)New MI, Carlson A, Obeid J, et al: Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies. J Clin Endocrinol Metab 86: 5651, 2001.
190) Premawardhana LDKE, Hughes IA, Read GF, Scanlon MF: Longer term outcome in females with congenital adrenal hyperplasia (CAH): the Cardiff experience. Clin Endocrinol 46: 327, 1997.
191) Feldman S, Billaud L, Thalabard J-C, et al: Fertility in women with late onset adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 74: 635, 1992.
192) Klingensmith GJ, Garcia SC, Jones HW, et al: Glucocorticoid treatment of girls with congenital adrenal hyperplasia: effect of height, sexual maturity, and fertility. J Pediatr 90: 996, 1977.
193) Krone N, Wachter I, Stafanidou M, Roscher AA, Schwarz HP: Mothers with congenital adrenal hyperplasia and their children: outcome of pregnancy, birth and childhood. Clin Endocrinol 55: 523, 2001.
194) New MI, Lorenzen F, Lerner AJ, et al: Genotyping sterioid 21-hydroxylase deficiency: hormonal reference data. J Clin Endocrinol Metab 57: 320, 1983.
195) Azziz R, DeWailly D, Owerbach D. Nonclassic adrenal hyperplasia: current concepts. J Clin Endocrinol Metab 78: 810, 1994.
196) Coleman MA, Honour JW: Reduced maternal dexamethasone dosage for the prenatal treatment of congenital adrenal hyperplasia. BJOG 111: 176, 2004.
197)Pang A, Pollack MS, Marshall RN, Immken LD. Prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med 322: 111, 1990.
198) Pang S, Clark AT, Freeman LC, et al. Maternal side effects of prenatal dexamethasone therapy for fetal congenital adrenal hyperplasia. J Clin Endocrinol Metab 75: 249, 1992.
199) Baron F, Sprauve ME, Huddleston JF, Fisher AJ: Diagnosis and surgical treatment of primary aldosteronism in pregnancy: a case report. Obstet Gynecol 86: 644, 1995.
200) Solomon CG, Thiet M-P, Moore F Jr, Seely EW: Primary hyperaldosteronism in pregnancy. A case report. J Reprod Med 41: 255, 1996.
201) Webb JC, Bayliss P: Pregnancy complicated by primary hyperaldosteronism. Southern Med J 90: 243, 1997.
202) Robar CA, Poremba JA, Pelton JJ, et al. Current diagnosis and management of aldosterone-producing adenomas during pregnancy. The Endocrinologist 8: 403, 1998.
203) Okawa T, Asano K, Hashimoto T, et al: Diagnosis and management of primary aldosteronism in pregnancy: case report and review of the literature. Am J Perinatol 19: 31, 2002.
204)Wyckoff JA, Seely EW, Hurwitz S, et al: Glucocorticoid-remediable aldosteronism and pregnancy. Hypertension 35: 668, 2000.
205)Fujiyama S, Mori Y, Matsubara H, et al: Primary aldosteronism with aldosterone-producing adrenal adenoma in a pregnant woman. Intern Med 38: 36, 1999.
206)Neerhof MG, Shlossman PA, Poll DS, et al: Idiopathic aldosteronism in pregnancy. Obstet Gynecol 78: 489, 1991.
207)Matsumoto J, Miyake H, Isozaki T, et al: Primary aldosteronism in pregnancy. J Nippon Med Sch 67: 275, 2000.
208)Deruelle P, Dufour P, Magnenant E, et al: Maternal Bartter’s syndrome in pregnancy treated by amiloride. Eur J Obstet Gynecol Reprod Biol 115: 106, 2004.
209)Nezo M, Miura Y, Noshiro T, Inoue M: Primary aldosteronism as a cause of severe postpartum hypertension in two women. Am J Obstet Gynecol 182: 745, 2000.
210) Murakami T, Ogura EW, Tanaka Y, Yamamoto M: High blood pressure lowered by pregnancy. Lancet 356: 1980, 2000.
211) Freier DT, Thompson NW: Pheochromocytoma and pregnancy: The epitome of high risk. Surgery 114: 1148, 1993.
212) Botchan A, Hauser R, Kupfermine M, et al: Pheochromocytoma in pregnancy: case report and review of the literature. Obstet Gynecol Surv 50: 321, 1995.
213)Levin N, McTighe A, Abdel-Aziz MIE. Extra-adrenal pheochromocytoma in pregnancy. Maryland State Med J 32: 377, 1983.
214) Oishi S, Sato T: Pheochromocytoma in pregnancy: a review of the Japanese literature. Endocrine J 41: 219, 1994.
215) Lau P, Permezel M, Dawson P, et al. Phaeochromocytoma in pregnancy. Aust N Z J Obstet Gynaecol 36: 472, 1996.
216) Saarikoski S: Fate of noradrenaline in the human fetoplacental unit. Acta Physiol Scand 421 (Suppl): 1, 1974.
217) Dahia PLM, Hayashida CY, Strunz C, Abelin N, Toledo SPA: Low cord blood levels of catecholamine from a newborn of a pheochromocytoma patient. Eur J Endocrinol 130: 217, 1994.
218) Barzel US, Barlian Z, Runmery G, et al: Pheochromocytoma and pregnancy. Am J Obstet Gynecol 89: 519, 1964.
219) Bakri YN, Ingemansson SE, Ali A, Parikh S: Pheochromocytoma and pregnancy: Report of three cases. Acta Obstet Gynecol Scand 71: 301, 1992.
220) Harper MA, Murnaghan GA, Kennedy L, Hadden DR, Atkinson AB: Phaeochromocytoma in pregnancy: Five cases and a review of the literature. Br J Obstet Gynaecol 96: 594, 1989.
221) Combs CA, Easterling TR, Schmucker BC: Hemodynamic observations during paroxysmal hypertension in a pregnancy with pheochromocytoma. Obstet Gynecol 74: 439, 1989.
222) Falterman CJ, Kreisberg R: Pheochromocytoma: Clinical diagnosis and management. South Med J 75: 321, 1982.
223) Kalff V, Shapiro B, Lloyd R, et al: The spectrum of pheochromocytoma in hypertensive patients with neurofibromatosis. Arch Intern Med 142: 2092, 1982.
224) Kothari A, Bethune M, Manwaring J, Astley N, Wallace E: Massive bilateral phaeochromocytomas in association with von Hippel Lindau syndrome in pregnancy. Aust NZ J Obstet Gynaecol 39: 381, 1999.
225) Freier DT, Eckhauser FE, Harrison TS: Pheochromocytoma. Arch Surg 115: 388, 1980.
226) Sheps SG, Jiang NS, Klee GC: Diagnostic evaluation of pheochromocytoma. Endocrinol Metab Clin North Am 17: 397, 1988.
227) Pederson EB, Rasmussen AB, Christensen NJ, et al: Plasma noradrenaline and adrenaline in pre-eclampsia, essential hypertension in pregnancy and normotensive pregnant control subjects. Acta Endocrinol (Copenh) 99: 594, 1982.
228) Moodley J, McFadyen ML, Dilraj A, Rangiah S. Plasma noradrenaline and adrenaline levels in eclampsia. S Afr Med J 80: 191, 1991.
229) Santeiro ML, Stromquist C, Wyble L: Phenoxybenzamine placental transfer during the third trimester. Ann Pharmacother 30: 1249, 1996.
230) Lyons CW, Colmorgen GHC: Medical management of pheochromocytoma in pregnancy. Obstet Gynecol 72: 450, 1988.
231) Ahlawat SK, Jain S, Kumari S, Varma S, Sharma BK: Pheochromocytoma associated with pregnancy: Case report and review of the literature. Obstet Gynecol Surv 54: 728, 1999.
232) Devoe LD, O’Dell BE, Castillo RA, Hadi HA, Searle N: Metastatic pheochromocytoma in pregnancy and fetal biophysical assessment after maternal administration of alpha-adrenergic, beta-adrenergic, and dopamine antagonists. Obstet Gynecol 68 (Suppl 3): 15S, 1986.
233) Chatterjee TK, Parekh U: Phaeochromocytoma in pregnancy. Aust NZ J Obstet Gynaecol 25: 290, 1985.
234) Finkenstedt G, Gasser RW, Hofle G, et al: Pheochromocytoma and sub-clinical Cushing’s syndrome during pregnancy: Diagnosis, medical pre-treatment and cure by laparoscopic unilateral adrenalectomy. J Endocrinol Invest 22: 551, 1999.
235) Schenker JG, Granat M: Phaeochromocytoma and pregnancy—An updated appraisal. Aust NZ J Obstet Gynaecol 22: 1, 1982.
Schenker JG, Chowers I: Pheochromocytoma and pregnancy: Review of 89 cases. Obstet Gynecol Surv 26: 739, 1971.